Yiba ngowokuqala we-D-Aspartic Acid - Isibuyekezo Sokungezelela

I-testosterone testosterone, ekhiqizwa ngumzimba wesilisa, ayigcini nje ngokuthinta ikhwalithi yokusebenza kwe-erectile, kepha futhi iyasiza ekwakheni ubukhulu bemisipha kubasubathi. IFarmaguida yenze isivivinyo samasonto amabili lapho abesilisa abaphakathi kweminyaka engama-27 nengama-37 babambe khona iqhaza. Bathathe ama-3120 gramu we-D-aspartic acid nsuku zonke. Ngemuva kwesikhathi esibonisiwe, kwenziwa ukukalwa kwemingcele ye-plasma yamakhemikhali, okwasungula ukwanda okukhulu kwamazinga e-testosterone.

Umkhiqizi ube ngowokuqala usungule isithasiselo sokudla i-D-Aspartic Acid, equkethe i-D-Aspartic acid egxilile. Yenza kusebenze umsebenzi we-hypothalamus ukukhiqiza i-hormone yowesilisa - i-testosterone.

Izici

Isengezo se-D-Aspartic Acid:

• isheshisa ukukhiqizwa kwe-testosterone;
• kwandisa izinga lokukhuthazela ngokomzimba;
• kusiza ukwakha ubukhulu bemisipha;
• ithuthukisa umsebenzi wezocansi wamadoda.

Ifomu lokukhishwa

Isengezo sitholakala ngesimo samaphilisi esinqamu sezingcezu eziyi-120 noma impuphu enesisindo esingu-200 amagremu, esenzelwe ama-servings angama-87.

Ukwakheka

Izingxenye ezingeziwe (ngama-capsules): i-aerosil (i-anti-caking agent), i-gelatin.

Imiyalo yokusetshenziswa

Nciphisa uhhafu wesamba sesengezo (cishe 2.3 g) engilazini yamanzi. Ukusetshenziswa kwezinye izinhlobo zoketshezi kuvunyelwe. Izinga lansuku zonke lingama-gramu ama-5, lihlukaniswe ngemithamo emibili ngosuku ngokudla.

Isengezo ngesimo samaphilisi sithathwa kathathu ngosuku, ucezu olu-1. Akunconyiwe ukweqa isilinganiso esinconyiwe.

Izimo

Isengezo siphikisiwe:

• abesifazane abakhulelwe;
• omama abahlengikazi;
• abantu abangaphansi kweminyaka engu-18.

Izimo zokugcina

Uma sekuvuliwe, iphakethe lokungezelela kufanele ligcinwe livaliwe liqinile endaweni epholile, emnyama kude nelanga eliqondile.

Intengo

Izindleko zesengezo zixhomeke kubungako bephakeji.

Bukela ividiyo: D aspartic Acid Supplement: Best D aspartic Acid Supplements for Male Fertility (May 2025).